What is the share price of Trident Lifeline Ltd (TLL) today?
The share price of TLL as on 12th March 2026 is ₹247. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Trident Lifeline Ltd (TLL) share?
The past returns of Trident Lifeline Ltd (TLL) share are- Past 1 week: -3.14%
- Past 1 month: -8.52%
- Past 3 months: -17.30%
- Past 6 months: -14.70%
- Past 1 year: -1.55%
- Past 3 years: 58.03%
- Past 5 years: 129.40%
What are the peers or stocks similar to Trident Lifeline Ltd (TLL)?
The peers or stocks similar to Trident Lifeline Ltd (TLL) include:What is the market cap of Trident Lifeline Ltd (TLL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Trident Lifeline Ltd (TLL) is ₹296.06 Cr as of 12th March 2026.What is the 52 week high and low of Trident Lifeline Ltd (TLL) share?
The 52-week high of Trident Lifeline Ltd (TLL) is ₹328 and the 52-week low is ₹237.What is the PE and PB ratio of Trident Lifeline Ltd (TLL) stock?
The P/E (price-to-earnings) ratio of Trident Lifeline Ltd (TLL) is 25.22. The P/B (price-to-book) ratio is 4.25.Which sector does Trident Lifeline Ltd (TLL) belong to?
Trident Lifeline Ltd (TLL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Trident Lifeline Ltd (TLL) shares?
You can directly buy Trident Lifeline Ltd (TLL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Trident Lifeline Ltd
TLL Share Price
BSE₹247.000.44% (-1.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TLL Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TLL Performance & Key Metrics
TLL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 15.28 | 4.25 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.97 | 5.84 | 0.58% |
TLL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
TLL Company Profile
Trident Lifeline Ltd produces and sells a wide range of medications, including capsules and syrups, operating in various international markets.
SUNPHARMA
PE Ratio
40.09
40.09
1Y Return
10.31%
10.31%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
78.47
78.47
1Y Return
44.91%
44.91%
Buy Reco %
81.48
81.48
DRREDDY
PE Ratio
19.51
19.51
1Y Return
18.70%
18.70%
Buy Reco %
51.61
51.61
CIPLA
PE Ratio
20.37
20.37
1Y Return
8.04%
8.04%
Buy Reco %
54.84
54.84
LUPIN
PE Ratio
32.65
32.65
1Y Return
18.65%
18.65%
Buy Reco %
72.22
72.22
TLL Forecast
TLL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
TLL
TLL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TLL Income Statement
TLL Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.31 | 7.34 | 20.59 | 14.30 | 15.99 | 12.39 | 35.88 | 24.96 | 33.01 | 30.34 | ||||||||||
Operating & Other expenses | 7.74 | 5.67 | 16.77 | 10.66 | 11.40 | 7.75 | 25.48 | 18.44 | 24.48 | 20.62 | ||||||||||
EBITDA | 2.57 | 1.67 | 3.82 | 3.64 | 4.59 | 4.64 | 10.40 | 6.52 | 8.53 | 9.72 | ||||||||||
| Depreciation/Amortization | 0.16 | 0.19 | 0.39 | 0.54 | 0.16 | 0.61 | 2.74 | 1.46 | 0.91 | 2.46 | ||||||||||
| PBIT | 2.41 | 1.48 | 3.43 | 3.10 | 4.43 | 4.03 | 7.66 | 5.06 | 7.62 | 7.26 | ||||||||||
| Interest & Other Items | 0.11 | 0.15 | 0.37 | 0.49 | 0.50 | 0.55 | 1.55 | 1.13 | 0.99 | 1.24 | ||||||||||
| PBT | 2.30 | 1.33 | 3.06 | 2.61 | 3.93 | 3.48 | 6.11 | 3.93 | 6.63 | 6.02 | ||||||||||
| Taxes & Other Items | 0.60 | 0.26 | 1.04 | 0.32 | 0.83 | 0.69 | -0.95 | 0.87 | 1.68 | 1.71 | ||||||||||
| Net Income | 1.70 | 1.07 | 2.02 | 2.29 | 3.10 | 2.79 | 7.06 | 3.06 | 4.95 | 4.31 | ||||||||||
| EPS | 1.48 | 0.94 | 1.41 | 1.99 | 2.69 | 2.42 | 6.15 | 2.66 | 4.27 | 3.72 |
TLL Company Updates
TLL Stock Peers
TLL Past Performance & Peer Comparison
TLL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Trident Lifeline Ltd | 25.22 | 4.25 | — |
| Sun Pharmaceutical Industries Ltd | 40.09 | 6.04 | 0.88% |
| Torrent Pharmaceuticals Ltd | 78.47 | 19.76 | 0.72% |
| Dr Reddy's Laboratories Ltd | 19.51 | 3.25 | 0.60% |
TLL Stock Price Comparison
Compare TLL with any stock or ETFCompare TLL with any stock or ETF
TLL
TLL Holdings
TLL Shareholdings
TLL Promoter Holdings Trend
TLL Promoter Holdings Trend
TLL Institutional Holdings Trend
TLL Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TLL Shareholding Pattern
TLL Shareholding Pattern
TLL Shareholding History
TLL Shareholding History
Foreign Institutions
smallcases containing TLL stock
smallcases containing TLL stock
Looks like this stock is not in any smallcase yet.
TLL Events
TLL Events
TLL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TLL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TLL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
TLL has not given any dividends in last 5 years
TLL Dividends
TLL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeTLL Stock News & Opinions
TLL Stock News & Opinions
Articles & Videos
Earnings
Trident Lifeline consolidated net profit rises 54.12% in the December 2025 quarter
Net profit of Trident Lifeline rose 54.12% to Rs 4.30 crore in the quarter ended December 2025 as against Rs 2.79 crore during the previous quarter ended December 2024. Sales rose 117.33% to Rs 25.71 crore in the quarter ended December 2025 as against Rs 11.83 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales25.7111.83 117 OPM %19.8034.49 - PBDT8.484.08 108 PBT6.023.48 73 NP4.302.79 54 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Trident Lifeline to table results
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 17 January 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Trident Lifeline hike stake in subsidiary - Trident Mediquip
Trident Lifeline has made further Investment by acquiring an additional equity stake of 9.04% of Trident Mediquip (TML) (CIN: U33309GJ2019PLC110421), a subsidiary company from existing shareholders of the Company. Pursuant to the above, the shareholding of the company in Trident Mediquip has increased from 51% to 60.04%. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Trident Lifeline standalone net profit rises 45.72% in the September 2025 quarter
Net profit of Trident Lifeline rose 45.72% to Rs 4.94 crore in the quarter ended September 2025 as against Rs 3.39 crore during the previous quarter ended September 2024. Sales rose 75.22% to Rs 27.44 crore in the quarter ended September 2025 as against Rs 15.66 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales27.4415.66 75 OPM %23.2528.22 - PBDT7.074.67 51 PBT6.484.51 44 NP4.943.39 46 Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Trident Lifeline to announce Quarterly Result
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Trident Lifeline schedules AGM
Trident Lifeline announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Trident Lifeline consolidated net profit rises 33.62% in the June 2025 quarter
Net profit of Trident Lifeline rose 33.62% to Rs 3.06 crore in the quarter ended June 2025 as against Rs 2.29 crore during the previous quarter ended June 2024. Sales rose 79.54% to Rs 23.61 crore in the quarter ended June 2025 as against Rs 13.15 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.6113.15 80 OPM %21.9019.01 - PBDT5.393.15 71 PBT3.932.61 51 NP3.062.29 34 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Trident Lifeline to declare Quarterly Results
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 28 July 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Trident Lifeline to convene board meeting
Trident Lifeline will hold a meeting of the Board of Directors of the Company on 28 April 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Trident Lifeline to convene EGM
Trident Lifeline announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 9 May 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has increased by 1.07%
Pledged promoter holdings is insignificant